Literature DB >> 25211073

Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies.

Thomas B Kepler1, Hua-Xin Liao2, S Munir Alam2, Rekha Bhaskarabhatla3, Ruijun Zhang2, Chandri Yandava3, Shelley Stewart2, Kara Anasti2, Garnett Kelsoe4, Robert Parks2, Krissey E Lloyd2, Christina Stolarchuk2, Jamie Pritchett2, Erika Solomon2, Emma Friberg2, Lynn Morris5, Salim S Abdool Karim6, Myron S Cohen7, Emmanuel Walter8, M Anthony Moody8, Xueling Wu9, Han R Altae-Tran9, Ivelin S Georgiev9, Peter D Kwong9, Scott D Boyd10, Andrew Z Fire10, John R Mascola9, Barton F Haynes11.   

Abstract

Induction of HIV-1 broad neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development but has remained challenging partially due to unusual traits of bnAbs, including high somatic hypermutation (SHM) frequencies and in-frame insertions and deletions (indels). Here we examined the propensity and functional requirement for indels within HIV-1 bnAbs. High-throughput sequencing of the immunoglobulin (Ig) VHDJH genes in HIV-1 infected and uninfected individuals revealed that the indel frequency was elevated among HIV-1-infected subjects, with no unique properties attributable to bnAb-producing individuals. This increased indel occurrence depended only on the frequency of SHM point mutations. Indel-encoded regions were generally proximal to antigen binding sites. Additionally, reconstruction of a HIV-1 CD4-binding site bnAb clonal lineage revealed that a large compound VHDJH indel was required for bnAb activity. Thus, vaccine development should focus on designing regimens targeted at sustained activation of bnAb lineages to achieve the required SHM and indel events.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25211073      PMCID: PMC4163498          DOI: 10.1016/j.chom.2014.08.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  47 in total

1.  Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop.

Authors:  Penny L Moore; Elin S Gray; Daniel Sheward; Maphuti Madiga; Nthabeleng Ranchobe; Zhong Lai; William J Honnen; Molati Nonyane; Nancy Tumba; Tandile Hermanus; Sengeziwe Sibeko; Koleka Mlisana; Salim S Abdool Karim; Carolyn Williamson; Abraham Pinter; Lynn Morris
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 2.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

3.  B cell responses to HIV-1 infection and vaccination: pathways to preventing infection.

Authors:  Barton F Haynes; M Anthony Moody; Hua-Xin Liao; Laurent Verkoczy; Georgia D Tomaras
Journal:  Trends Mol Med       Date:  2010-11-26       Impact factor: 11.951

Review 4.  Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.

Authors:  Laurent Verkoczy; Garnett Kelsoe; M Anthony Moody; Barton F Haynes
Journal:  Curr Opin Immunol       Date:  2011-04-27       Impact factor: 7.486

5.  Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2.

Authors:  Hua-Xin Liao; Mattia Bonsignori; S Munir Alam; Jason S McLellan; Georgia D Tomaras; M Anthony Moody; Daniel M Kozink; Kwan-Ki Hwang; Xi Chen; Chun-Yen Tsao; Pinghuang Liu; Xiaozhi Lu; Robert J Parks; David C Montefiori; Guido Ferrari; Justin Pollara; Mangala Rao; Kristina K Peachman; Sampa Santra; Norman L Letvin; Nicos Karasavvas; Zhi-Yong Yang; Kaifan Dai; Marie Pancera; Jason Gorman; Kevin Wiehe; Nathan I Nicely; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Faruk Sinangil; Jerome H Kim; Nelson L Michael; Thomas B Kepler; Peter D Kwong; John R Mascola; Gary J Nabel; Abraham Pinter; Susan Zolla-Pazner; Barton F Haynes
Journal:  Immunity       Date:  2013-01-11       Impact factor: 31.745

6.  Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection.

Authors:  Peter Hraber; Michael S Seaman; Robert T Bailer; John R Mascola; David C Montefiori; Bette T Korber
Journal:  AIDS       Date:  2014-01-14       Impact factor: 4.177

7.  In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth.

Authors:  Xiaoying Shen; Robert J Parks; David C Montefiori; Jennifer L Kirchherr; Brandon F Keele; Julie M Decker; William A Blattner; Feng Gao; Kent J Weinhold; Charles B Hicks; Michael L Greenberg; Beatrice H Hahn; George M Shaw; Barton F Haynes; Georgia D Tomaras
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

8.  Location and length distribution of somatic hypermutation-associated DNA insertions and deletions reveals regions of antibody structural plasticity.

Authors:  B S Briney; J R Willis; J E Crowe
Journal:  Genes Immun       Date:  2012-06-21       Impact factor: 2.676

9.  An insertion mutation that distorts antibody binding site architecture enhances function of a human antibody.

Authors:  Jens C Krause; Damian C Ekiert; Terrence M Tumpey; Patricia B Smith; Ian A Wilson; James E Crowe
Journal:  MBio       Date:  2011-02-08       Impact factor: 7.867

10.  Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors.

Authors:  Thomas B Kepler
Journal:  F1000Res       Date:  2013-04-03
View more
  74 in total

Review 1.  Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.

Authors:  Dennis R Burton; Lars Hangartner
Journal:  Annu Rev Immunol       Date:  2016-05-20       Impact factor: 28.527

2.  Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites.

Authors:  Katie L Winarski; Natalie J Thornburg; Yingchun Yu; Gopal Sapparapu; James E Crowe; Benjamin W Spiller
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

3.  A sense of immunity: scientists are detailing the immune system as never before.

Authors:  Amanda B Keener
Journal:  Nat Med       Date:  2015-01       Impact factor: 53.440

Review 4.  The evolution within us.

Authors:  Sarah Cobey; Patrick Wilson; Frederick A Matsen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

Review 5.  What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Lessons from the Antibody Response to HIV-1.

Authors:  Gabriel D Victora; Hugo Mouquet
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

6.  VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing Lineage.

Authors:  Chen-Hsiang Shen; Brandon J DeKosky; Yicheng Guo; Kai Xu; Ying Gu; Divya Kilam; Sung Hee Ko; Rui Kong; Kevin Liu; Mark K Louder; Li Ou; Baoshan Zhang; Cara W Chao; Martin M Corcoran; Eric Feng; Jesse Huang; Erica Normandin; Sijy O'Dell; Amy Ransier; Reda Rawi; Mallika Sastry; Stephen D Schmidt; Shuishu Wang; Yiran Wang; Gwo-Yu Chuang; Nicole A Doria-Rose; Bob Lin; Tongqing Zhou; Eli A Boritz; Mark Connors; Daniel C Douek; Gunilla B Karlsson Hedestam; Zizhang Sheng; Lawrence Shapiro; John R Mascola; Peter D Kwong
Journal:  Cell Host Microbe       Date:  2020-03-03       Impact factor: 21.023

7.  Immunogenetic factors driving formation of ultralong VH CDR3 in Bos taurus antibodies.

Authors:  Thaddeus C Deiss; Melissa Vadnais; Feng Wang; Patricia L Chen; Ali Torkamani; Waithaka Mwangi; Marie-Paule Lefranc; Michael F Criscitiello; Vaughn V Smider
Journal:  Cell Mol Immunol       Date:  2017-12-04       Impact factor: 11.530

8.  In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable region.

Authors:  Kalliopi Skamaki; Stephane Emond; Matthieu Chodorge; John Andrews; D Gareth Rees; Daniel Cannon; Bojana Popovic; Andrew Buchanan; Ralph R Minter; Florian Hollfelder
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-16       Impact factor: 11.205

9.  HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant.

Authors:  Cassandra A Simonich; Katherine L Williams; Hans P Verkerke; James A Williams; Ruth Nduati; Kelly K Lee; Julie Overbaugh
Journal:  Cell       Date:  2016-06-23       Impact factor: 41.582

10.  Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding.

Authors:  Nancy S Longo; Matthew S Sutton; Andrea R Shiakolas; Javier Guenaga; Marissa C Jarosinski; Ivelin S Georgiev; Krisha McKee; Robert T Bailer; Mark K Louder; Sijy O'Dell; Mark Connors; Richard T Wyatt; John R Mascola; Nicole A Doria-Rose
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.